normal human astrocyte (nha, lonza bioscience, westlake, la, usa) cell line (Lonza)
90
Structured Review
Lonza
normal human astrocyte (nha, lonza bioscience, westlake, la, usa) cell line
Normal Human Astrocyte (Nha, Lonza Bioscience, Westlake, La, Usa) Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+human+astrocytes+cell+line/normal+human+astrocytes/pm40149331-54-13-8
Average 90 stars, based on 1 article reviews
Normal Human Astrocyte (Nha, Lonza Bioscience, Westlake, La, Usa) Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+human+astrocytes+cell+line/normal+human+astrocytes/pm40149331-54-13-8
Average 90 stars, based on 1 article reviews
normal human astrocyte (nha, lonza bioscience, westlake, la, usa) cell line - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models Article Snippet: Article Title: Multi-Omics Integrative Analysis Coupled to Control Theory and Computational Simulation of a Genome-Scale metabolic Model Reveal Controlling Biological Switches in Human Astrocytes Under Palmitic Acid-Induced Lipotoxicity Article Snippet: Transcriptome and proteome data was obtained by our laboratory from Article Title: The possible prognostic role of histone deacetylase and transforming growth factor β/ Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study Article Snippet: Article Title: HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells. Article Snippet: The role of histone deacetylase (HDAC) 4 and 6 in glioblastoma (GBM) radioresistance was investigated.. We found that tumor samples from 31 GBM patients, who underwent temozolomide and radiotherapy combined treatment, showed HDAC4 and HDAC6 expression in 93.5% and 96.7% of cases, respectively.. Retrospective clinical data analysis demonstrated that high-intensity HDAC4 and/or HDAC6 immunostaining was predictive of poor clinical outcome. |